The HSPG-mediated signaling activation of HGF released in the tumor microenvironment and of its receptor c-MET promotes ECM remodeling, inflammation, migration, angiogenesis, and invasion [182,183,184]. The gene discussed is HSPG2; the disease is neoplasm.